Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

FDA approves Lilly’s once weekly Onswik insulin for adults with type 2 diabetes


Bio Techne shareholders approve acquisition by Merck KGaA


FDA approves Kerendia for chronic kidney disease linked to type 1 diabetes


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Assessing the Risk of Interaction Between Extractables and Leachable and Therapeutic Proteins

Presented by Andrew Teasdale, Senior Principal Scientist Impurity management and External Advocacy at AstraZeneca & Piet Christieans, PhD, Scientific Director at Nelson Lab
14th May 2020


Evolve Manufacturing Processes by Implementing Disruptive Technologies

Presented by Presented Yuyi Shen, Associate Director and Head of Development & Manufacturing at Bolt Biotherapeutics and John Cyganowski, Director of Manufacturing Sciences and Technologies Downstream Americas for MilliporeSigma
19th November 2018


Antisense Oligonucleotide Purification Process: Successes and Challenges During Scale-up

Presented by Robert Gronke, Ph.D., Senior Principal Scientist, Technical Development, Biogen and Thomas Müller-Späth, Ph.D, CTO at YMC ChromaCon
10th March 2020


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia